Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner

Scientific Reports

Volumn 5, Issue , 2015, Pages

  McGrail, Daniel J ^a   Khambhati, Niti N ^b   Qi, Mark X ^a   Patel, Krishan S ^a   Ravikumar, Nithin ^a   Brandenburg, Chandler P ^b   Dawson, Michelle R ^a,b  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA1 INTEGRIN; FOCAL ADHESION KINASE; PACLITAXEL;

ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; MICROTUBULE; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD29; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICROTUBULES; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 84928485063     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09529     Document Type: Article

References (70)

1. Jemal, A., Siegel, R., Xu, J. &Ward, E. Cancer statistics, 2010. CA. Cancer J. Clin. 60, 277-300 (2010).
2. Hennessy, B. T., Coleman, R. L. & Markman, M. Ovarian cancer. Lancet 374, 1371-82 (2009).
3. Kumar, S. et al. Clinical trials and progress with paclitaxel in ovarian cancer. Int. J. Womens. Health 2, 411-27 (2010).
4. Coleman, R., Monk, B., Sood, A. & Herzog, T. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 10, 211-224 (2013).
5. Agarwal, R. & Kaye, S. B. Ovarian cancer: Strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 3, 502-16 (2003).
6. Kavallaris, M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 10, 194-204 (2010).
7. Horwitz, S. B. et al. Taxol: Mechanisms of action and resistance. J. Natl. Cancer Inst. Monogr. 15, 55-61 (1993).
8. Di Michele, M. et al. A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim. Biophys. Acta 1794, 225-36 (2009).
9. Gonçalves, A. et al. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. U. S. A. 98, 11737-42 (2001).
10. Kavallaris, M. et al. Taxol-resistant Epithelial Ovarian Tumors Are Associated with Altered Expression of Specific B-Tubulin Isotypes. J. Clin. Invest 100, 1282-1293 (1997).
11. Cabral, F. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin. Proc. Natl. Acad. Sci. 78, 4388-4391 (1981).
12. Zasadil, L. M. et al. Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles. Sci. Transl. Med. 6, 229ra43-229ra43 (2014).
13. Wirtz, D., Konstantopoulos, K. & Searson, P. C. The physics of cancer: The role of physical interactions and mechanical forces in metastasis. Nat. Rev. Cancer 11, 512-22 (2011).
14. Kajiyama, H. et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol. 31, 277-83 (2007).
15. Kenny, H. & Kaur, S. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest 118, 1367-1379 (2008).
16. Vicente-Manzanares, M. & Horwitz, A. R. Adhesion dynamics at a glance. J. Cell Sci. 124, 3923-7 (2011).
17. Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: Biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22 (2010).
18. Arboleda, M. J. et al. Overexpression of AKT2/Protein Kinase B{beta} Leads to Up-Regulation of {beta}1 Integrins, Increased Invasion, and Metastasis of Human Breast and Ovarian Cancer Cells. Cancer Res. 63, 196-206 (2003).
19. Strobel, T. & Cannistra, S. A. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol. Oncol. 73, 362-7 (1999).
20. Slack-Davis, J. K., Atkins, K. A., Harrer, C., Hershey, E. D. & Conaway, M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res. 69, 1469-76 (2009).
21. Landen, C., Kim, T., Lin, Y.&Merritt, W. Tumor-Selective Response to Antibody-Mediated Targeting of a v b 3 Integrin in Ovarian Cancer. Neoplasia 10, 1259-1267 (2008).
22. Palazzo, A. F., Eng,C.H., Schlaepfer, D. D.,Marcantonio, E. E.&Gundersen,G.G. Localized stabilization of microtubules by integrin-and FAK-facilitated Rho signaling. Science 303, 836-9 (2004).
23. Efimov, A. et al. Paxillin-dependent stimulation of microtubule catastrophes at focal adhesion sites. J. Cell Sci. 121, 405-405 (2008).
24. Etienne-Manneville, S. Microtubules in cell migration. Annu. Rev. Cell Dev. Biol. 29, 471-99 (2013).
25. Debernardis, D., Siré, E. & Feudis, P. De. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res. 57, 870-874 (1997).
26. Jang, S. H.,Wientjes, M. G. & Au, J. L. Kinetics of P-glycoprotein-mediated efflux of paclitaxel. J. Pharmacol. Exp. Ther. 298, 1236-42 (2001).
27. Matov, A. et al. Analysis of microtubule dynamic instability using a plus-end growth marker. Nat. Methods 7, 761-8 (2010).
28. Ezratty, E. J., Partridge, M. A. & Gundersen, G. G. Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat. Cell Biol. 7, 581-90 (2005).
29. Rape, A., Guo, W. & Wang, Y. Microtubule depolymerization induces traction force increase through two distinct pathways. J. Cell Sci. 124, 4233-40 (2011).
30. Elineni, K. K. &Gallant, N. D. Microtubules Mechanically Regulate Cell Adhesion Strengthening Via Cell Shape. Cell. Mol. Bioeng. 7, 136-144 (2013).
31. Bershadsky, A., Chausovsky, A., Becker, E., Lyubimova, A. & Geiger, B. Involvement of microtubules in the control of adhesion-dependent signal transduction. Curr. Biol. 6, 1279-89 (1996).
32. Subauste, M. C. et al. Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165, 371-81 (2004).
33. Beningo, K. A., Dembo, M., Kaverina, I., Small, J. V. &Wang, Y. L. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J. Cell Biol. 153, 881-8 (2001).
34. Slack-Davis, J. K. et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 282, 14845-52 (2007).
35. Duan, Z., Lamendola, D. E., Duan, Y., Yusuf, R. Z. & Seiden, M. V. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines. Cancer Chemother. Pharmacol. 55, 277-85 (2005).
36. Fracasso, P. M. et al. Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: A gynecologic oncology group study. J. Clin. Oncol. 19, 2975-82 (2001).
37. Penson, R. T. et al. Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: A study in serial samples. Gynecol. Oncol. 93, 98-106 (2004).
38. Parekh, H., Wiesen, K. & Simpkins, H. Acquisition of taxol resistance via Pglycoprotein-and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochem. Pharmacol. 53, 461-70 (1997).
39. Orr, G. A., Verdier-Pinard, P., McDaid, H. & Horwitz, S. B. Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280-95 (2003).
40. Kaverina, I., Krylyshkina, O. & Small, J. V. Microtubule Targeting of Substrate Contacts Promotes Their Relaxation. J. Cell Biol. 146, 1033-1043 (1999).
41. Stehbens, S. J. et al. CLASPs link focal-adhesion-associated microtubule capture to localized exocytosis and adhesion site turnover. Nat. Cell Biol. 16, (2014).
42. Belotti, D. et al. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. Clin. Cancer Res. 2, 1725-30 (1996).
43. Michael, K. E., Dumbauld, D.W., Burns, K. L., Hanks, S. K. & García, A. J. Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. Mol. Biol. Cell 20, 2508-19 (2009).
44. Salaycik, K. J., Fagerstrom, C. J., Murthy, K., Tulu, U. S. & Wadsworth, P. Quantification of microtubule nucleation, growth and dynamics in wound-edge cells. J. Cell Sci. 118, 4113-22 (2005).
45. Horiuchi, A. et al. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer. Cancer Sci. 99, 2532-9 (2008).
46. Gallant, N.,Michael, K.&García, A. Cell adhesion strengthening: Contributions of adhesive area, integrin binding, and focal adhesion assembly. Mol. Biol. Cell 16, 4329-4340 (2005).
47. Gallant, N. D. & García, A. J. Model of integrin-mediated cell adhesion strengthening. J. Biomech. 40, 1301-9 (2007).
48. Schaller, M. D. Cellular functions of FAK kinases: Insight into molecular mechanisms and novel functions. J. Cell Sci. 123, 1007-13 (2010).
49. Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154-61 (2004).
50. Halder, J. et al. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin. Cancer Res. 11, 8829-36 (2005).
51. Kang, Y. et al. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J. Natl. Cancer Inst. 105, 1485-95 (2013).
52. Sood, A., Coffin, J. & Schneider, G. Biological significance of focal adhesion kinase in ovarian cancer: Role in migration and invasion. Am. J. Pathol. 165, 1087-1095 (2004).
53. Gundem, G. et al. IntOGen: Integration and data mining of multidimensional oncogenomic data. Nat. Methods 7, 92-3 (2010).
54. Infante, J. R. et al. Safety, pharmacokinetic, and pharmacodynamic phase I doseescalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. J. Clin. Oncol. 30, 1527-33 (2012).
55. Gupton, S. L. & Waterman-Storer, C. M. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125, 1361-74 (2006).
56. Iwanicki, M. et al. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 1, 144-157 (2011).
57. Scalici, J. M. et al. Inhibition of a4b1 integrin increases ovarian cancer response to carboplatin. Gynecol. Oncol. 132, 455-61 (2014).
58. Zutter, M. M. Integrin-mediated adhesion: Tipping the balance between chemosensitivity and chemoresistance. Adv. Exp. Med. Biol. 608, 87-100 (2007).
59. Oshita, F. et al. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am. J. Clin. Oncol. 27, 215-9 (2004).
60. Lane, D., Goncharenko-Khaider, N., Rancourt, C. & Piché, A. Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrinmediated focal adhesion kinase and Akt activation. Oncogene 29, 3519-31 (2010).
61. Smith, J. A., Ngo, H., Martin, M. C. & Wolf, J. K. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol. Oncol. 98, 141-5 (2005).
62. McGrail, D. J., McAndrews, K. M. & Dawson, M. R. Biomechanical analysis predicts decreased human mesenchymal stem cell function before molecular differences. Exp. Cell Res. 319, 684-96 (2013).
63. Eaton, S. L. et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One 8, e72457 (2013).
64. Welinder, C. & Ekblad, L. Coomassie staining as loading control inWestern blot analysis. J. Proteome Res. 10, 1416-9 (2011).
65. Minotti, A., Barlow, S. & Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J. Biol. Chem. 266, 3987-3994 (1991).
66. McGrail, D. J., Ghosh, D., Quach, N. D. & Dawson, M. R. Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. PLoS One 7, e33248 (2012).
67. Jaqaman, K., Loerke, D. & Mettlen, M. Robust single-particle tracking in live-cell time-lapse sequences. Nat. Methods 5, 695-702 (2008).
68. McGrail, D. J., Mezencev, R., Kieu, Q. M. N., McDonald, J. F. & Dawson, M. R. SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. FASEB J. doi:10.1096/fj.14-257345 (2014).
69. McGrail, D. J., Kieu, Q. M. N. & Dawson, M. R. The malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway. J. Cell Sci. 127, 2621-6 (2014).
70. Sabass, B., Gardel, M. L., Waterman, C. M. & Schwarz, U. S. High resolution traction force microscopy based on experimental and computational advances. Biophys. J. 94, 207-20 (2008).